Dashboard
1
With a fall in PBT of -293.91%, the company declared Very Negative results in Mar 26
- The company has declared negative results for the last 2 consecutive quarters
- NET PROFIT(HY) At VND -11,491.45 MM has Grown at -117.96%
- ROCE(HY) Lowest at -3.88%
- RAW MATERIAL COST(Y) Grown by 390.43% (YoY)
2
Risky -
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
VND Million (Micro Cap)
0
NA
0.00%
0.09
-3.89%
0.00
Revenue and Profits:
Net Sales:
7,234 Million
(Quarterly Results - Mar 2026)
Net Profit:
-8,247 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-13.33%
0%
-13.33%
6 Months
-55.17%
0%
-55.17%
1 Year
-66.67%
0%
-66.67%
2 Years
-64.86%
0%
-64.86%
3 Years
-89.03%
0%
-89.03%
4 Years
-89.12%
0%
-89.12%
5 Years
-86.0%
0%
-86.0%
American Vietnamese Biotech, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.30%
EBIT Growth (5y)
-212.98%
EBIT to Interest (avg)
1.40
Debt to EBITDA (avg)
6.03
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.14
Tax Ratio
0.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.88%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
1.42
EV to EBITDA
15.67
EV to Capital Employed
-0.04
EV to Sales
-0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-3.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
7,233.90
39,522.10
-81.70%
Operating Profit (PBDIT) excl Other Income
1,300.90
10,951.20
-88.12%
Interest
1,902.90
4,983.00
-61.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-8,247.10
-3,293.60
-150.40%
Operating Profit Margin (Excl OI)
-957.60%
52.20%
-100.98%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -81.70% vs 211.42% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -150.40% vs 69.68% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
159,667.20
310,354.60
-48.55%
Operating Profit (PBDIT) excl Other Income
-10,154.50
19,689.90
-151.57%
Interest
18,655.30
19,650.50
-5.06%
Exceptional Items
22.90
0.00
Consolidate Net Profit
-74,496.40
-13,065.20
-470.19%
Operating Profit Margin (Excl OI)
-275.80%
-13.90%
-26.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -48.55% vs 57.88% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -470.19% vs -221.74% in Dec 2024
About American Vietnamese Biotech, Inc. 
American Vietnamese Biotech, Inc.
Pharmaceuticals & Biotechnology
American Vietnamese Biotech Incorporation (AmviBiotech) is a Vietnam-based company engaged in the pharmaceutical industry. The Company is involved in the manufacture of medicines, vaccines and biological products. It is also involved in the manufacture of rapid diagnostic tests and ELISA kits, as well as the trading of other medical equipment and tools. In addition, the Company is active in the manufacture of cosmetic, soaps, detergents and other polishing and cleaning products. Its other activities include real estate trading, financial investment and the manufacture of plastic products. As of December 31, 2012, the Company had one wholly owned subsidiary named American - Vietnamese Biology Company Limited.
Company Coordinates 
Company Details
So 1251 QL 14, thi xa Dong Xoai , HO CHI MINH None : None
Registrar Details






